Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Regeneron highlighted that about 35% of weight loss from semaglutide alone was due to lean mass loss, which combo therapies ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

The company is preparing a Phase 3 trial of enobosarm with a novel formulation that could extend its patent life.

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the ...

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...

The telehealth site will welcome its own small-dose, compounded version of semaglutide, which mimics the function of a GLP-1.